
Investors
Sciensus proudly sitting at the intersection of patients and medicine
Sciensus is a specialty pharma services business which proudly sits at the intersection of patients and their medicine, specifically those patients with long-term conditions, rare and orphan diseases, and cancer. Using our 70 million patient interactions, which are growing exponentially on our digital platform, we are uncovering data and insight about patients and their medicine. We use this to deploy innovative programmes for patients, as well as providing valuable insight and real-world evidence for both Physicians and Pharmaceutical companies.

Our approach
Engaging patients to become more active participants in their health is crucial in driving positive change in healthcare. Our unparalleled insights, cutting edge research and smart, intuitive technology are designed to connect with people powerfully and personally, focusing on their unique needs and supporting them every step of the way.

Our markets
With the overall aim of increasing patient engagement to life-changing treatment and medication, our focus is on long-term conditions, cancer, and rare diseases.

Our services
We provide bespoke end-to-end services built on exceptional insight and experience in our key markets to connect pharmaceutical companies, insurers and healthcare professionals to patients.
Strategy and objectives
We recognise the world is changing faster than ever. New technologies have reshaped the way we live, redrawn the healthcare landscape and redefined the expectations of patients everywhere. At Sciensus, we are ambitious in our purpose to pioneer a new era of digitally enabled patient benefits.
Our vision
To be the global leader in helping each and every patient make the most of their medicine.
Our mission
To give patients control of their health through knowledge, choice, convenience and connection.
Financials

Making a positive impact
How we’re taking responsibility through our Environmental, Social & Governance strategy.
Our digital solutions
We believe that the Patient should sit at the centre of our strategy and that building a strong service relationship with the patient positions us well within the health eco-system, to provide better health outcomes. Our growth plans rest on this patient centricity, a determination to execute to the highest level of quality, earning us the right to deliver further value add services to our customers.
Our commitment to excellence has been evidenced through our continued investments in digital solutions including portals for the NHS, Clinicians, life science companies and European hospital pharmacies. We have further invested in our Patient Apps and an Online Patient Community.

Who we work with
News & Insights

Thought Leadership
Navigating expanded access in Europe: a strategic blueprint for biotech leaders

Blog
Our digital support pilot is showing early signs of success in improving patient health outcomes
A pilot of our digital support programme to help patients take their medicine more effectively has proven to be successful…

Blog
Accessing and supporting EU rare disease patients: a quick guide
Overcoming challenges in finding rare disease patients in Europe Rare diseases mean rare patients. In Europe ‘rare’ is defined as…
Partner with experience and expertise
If you’d like to find out how our partnerships can power your business, just contact us.